SCHEMBL1614307

SCHEMBL1614307

CC(C)c1ccc(CN2C(=O)S/C(=C\c3ccc(O)c(C(F)(F)F)c3)C2=O)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC2A1 P11166 2/20 0.66
▸ PTPN1 P18031 4/20 0.53
▸ ACP1 P24666 4/20 0.53
▸ PIM1 P11309 1/20 0.50
▸ S1PR1 P21453 2/20 0.48
▸ S1PR3 Q99500 1/20 0.48
▸ NLRP3 Q96P20 1/20 0.47
▸ ENPP2 Q13822 3/20 0.47
▸ PPARG P37231 1/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ POLB P06746 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ CRHBP P24387 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ CRHR2 Q13324 1/20 0.46
▸ NOD2 Q9HC29 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1614304 0.89 SLC2A1 (0.52) SLC2A1PTPN1ACP1PIM1S1PR1
SCHEMBL13754218 0.89 SLC2A1 (0.64) SLC2A1PTPN1ACP1PIM1NLRP3
SCHEMBL1615013 0.87 SLC2A1 (0.66) SLC2A1PTPN1ACP1PIM1S1PR1
SCHEMBL2171655 0.87 SLC2A1 (0.66) SLC2A1PTPN1ACP1PIM1NLRP3
SCHEMBL2171659 0.87 SLC2A1 (0.66) SLC2A1PTPN1ACP1PIM1NLRP3
SCHEMBL1614982 0.87 SLC2A1 (0.66) SLC2A1PTPN1ACP1PIM1NLRP3
SCHEMBL12712430 0.86 PTPN1 (0.56) SLC2A1PTPN1ACP1S1PR1S1PR3
SCHEMBL2175486 0.84 SLC2A1 (0.61) SLC2A1PTPN1ACP1PIM1NLRP3
SCHEMBL12406497 0.84 SLC2A1 (0.61) SLC2A1PTPN1ACP1PIM1NLRP3
SCHEMBL2175489 0.84 SLC2A1 (0.61) SLC2A1PTPN1ACP1PIM1NLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383656-B2 Thiazolidinedione energy restriction-mimetic agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-02-26 — — US disclosed
US-8383656-B2 Thiazolidinedione energy restriction-mimetic agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-02-26 — — US disclosed
EP-2488027-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS The Ohio State University Research Foundation (US) 2012-08-22 — — EP disclosed
WO-2011044548-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — WO disclosed
WO-2011044548-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — WO disclosed
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — US disclosed
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS PCK2, AK2, SIRT6 SLC2A1 76/4885PTPN1 863/4885ACP1 1572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback